Health & Medical · Week of Nov 2, 2026
CVS Health plans split as Q3 earnings dominate health news
Q3 earnings dominated, with CVS Health planning a two-way split, a board change at DarioHealth, a flood closure and a Parkinson's education effort.
Third-quarter results made up much of the week. Caris Life Sciences reported revenue of $275.4 million, up 27%, and raised its full-year 2026 revenue guidance to $1.04 to $1.05 billion. Syra Health reported a third consecutive profitable quarter on record revenue of $2,557,295, and Community Healthcare Trust posted FFO of $0.54 per diluted share alongside an unchanged $0.33 dividend. Encompass Health reaffirmed its full-year guidance despite closing a flood-damaged hospital in Melbourne, Florida.
The largest structural news came from CVS Health, which says it intends to separate into two publicly traded companies, with completion expected in the first half of 2028. Governance and patient education rounded out the week: DarioHealth named John R. Palumbo Chairman of the Board, and Medtronic and The Michael J. Fox Foundation for Parkinson's Research launched a deep brain stimulation education initiative, announced in releases from both organizations.
Caris Life Sciences
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Caris Life Sciences reported third-quarter 2026 revenue of $275.4 million, up 27% year over year, and net income of $15.3 million, with about 61,500 clinical cases completed. It raised full-year 2026 revenue guidance to $1.04 to $1.05 billion, although gross margin fell to 66% from 68% and free cash flow was $(39.7) million.
Community Healthcare Trust Incorporated
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026
Community Healthcare Trust reported net income of about $3.1 million, or $0.09 per diluted share, and FFO of $0.54 per diluted share for the quarter ended September 30, 2026, and declared a $0.33 dividend payable November 25, 2026. The company says it has completed $32.3 million in property dispositions since the second quarter closed and has four properties under definitive purchase agreements totaling about $99.0 million.
Syra Health
Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Syra Health reported third-quarter 2026 net income of $344,610 on revenue of $2,557,295, up 52%, which the company says is its highest quarterly revenue, with gross margin of 46.3%. The company says that following CMS approval of Syrenity for the ACCESS Model, it is recruiting Accountable Care Organizations to use Syrenity with partner HealthSync.
CVS Health
CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare
CVS Health says it intends to separate into two independent public companies. One, with the interim name CVS Health and led by David Joyner, would hold Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health; the other, CVS Pharmacy, led by Prem Shah, would hold about 9,000 pharmacies, mail pharmacy, MinuteClinic and Health100. The company expects to complete the separation in the first half of 2028, subject to conditions including final board approval and confirmation of tax-free treatment.
DarioHealth Corp.
Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded Care
DarioHealth appointed John R. Palumbo, a director since April 2026 and a former Chief Operating Officer of Allscripts Healthcare Solutions, as Chairman of the Board effective November 3, 2026, succeeding Yoav Shaked, who remains a director. The company says more than 80% of its contracted and late-stage annual recurring revenue is multi-condition, and Palumbo will join its November 12, 2026 earnings call.
Encompass Health Corp.
Encompass Health announces indefinite closure of Sea Pines Rehabilitation Hospital due to flood damage
Encompass Health says its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, is closed indefinitely after flooding on Nov. 1-2, 2026, and that all patients were safely evacuated. The company reaffirmed full-year 2026 guidance of $6,450 million to $6,500 million in Net operating revenue; Sea Pines contributed about $14 million to Adjusted EBITDA in the first nine months of 2026.
Medtronic plc
Medtronic and Michael J. Fox Foundation Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
Medtronic and The Michael J. Fox Foundation launched a deep brain stimulation education initiative for people with Parkinson's and their caregivers, including "The Live On with DBS Education Hub" at michaeljfox.org/dbs. Medtronic funds the initiative as premier partner, and MJFF says it keeps editorial oversight of the materials.
The Michael J. Fox Foundation for Parkinson's Research; Medtronic
Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
In its own release on the same initiative, MJFF says the materials cover how DBS works, its potential benefits and risks, surgery preparation and life with a DBS device. The foundation says it has funded more than $29 million in DBS research for Parkinson's since 2000.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not ZenFlex Wire reporting.